Cannabinoids are a group of chemicals that lie in the marijuana plant (cannabis sativa). They include chemicals such as tetrahydrocannabinol (THC), the psychoactive part of cannabis, and cannabidiol (CBD). Cannabidiol is said to have an anti-inflammatory effect in animal cells and a lot of research has been taking place in its properties. The paper will review how CBD could regulate a decrease in Id-1 expression in people with malignant cells arising from breast cancer.
Here is the full scientific article if you wish to download it.
Due to cannabinoids low toxicological profile, CBD’s have the potential to inhibit Id-1 gene expression correlated with those of breast cancer cells. Id-1 is a protein in humans that allows normal regulation in cells. CBD administration resulted in the Id-1 expression being inhibited at protein level in a dose-dependent fashion. CBD did not allow cells to be produced at an invasive level. This is the first time CBD has been seen to decrease 1d-1 expression in breast cancer cells. This is huge as CBD could possibly be used as an anti-tumor drug.
CBD is known to have an anti-inflammatory effect on animal cells, this has been followed up on human trials and it dose in fact contain anti-inflammatory properties.. This study shows that CBD may reduce tumor size through this apoptosis effect. There have been significant studies into this therapeutic property of CBD, however, because CBD is associated with THC and the psychotropic effects of cannabis, there is a struggle in getting it legal and available for breast cancer patients.
While CBD has gained a lot of attention around the world, studies on the oil and the lack of knowledge on side effects mean that it’s important that you take precautions and consult your doctor or medical professional.